David Hakimian

1.6k total citations
48 papers, 1.1k citations indexed

About

David Hakimian is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, David Hakimian has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 18 papers in Pathology and Forensic Medicine and 11 papers in Oncology. Recurrent topics in David Hakimian's work include Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (16 papers) and Viral-associated cancers and disorders (9 papers). David Hakimian is often cited by papers focused on Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (16 papers) and Viral-associated cancers and disorders (9 papers). David Hakimian collaborates with scholars based in United States, Israel and Philippines. David Hakimian's co-authors include Martin S. Tallman, Daina Variakojis, MS Tallman, Esther Rose, Gary S. Lissner, John M. Shaw, LoAnn C. Peterson, LoAnn Peterson, Alfred Rademaker and Frederick R. Rickles and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David Hakimian

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hakimian United States 17 657 446 306 295 274 48 1.1k
Pasquale Iacopino Italy 21 394 0.6× 210 0.5× 294 1.0× 774 2.6× 405 1.5× 72 1.3k
Jamile M. Shammo United States 17 587 0.9× 227 0.5× 296 1.0× 874 3.0× 305 1.1× 79 1.5k
Karim Maloum France 19 1.2k 1.9× 920 2.1× 612 2.0× 336 1.1× 205 0.7× 51 1.6k
Francesc Cobo Spain 18 650 1.0× 573 1.3× 176 0.6× 352 1.2× 367 1.3× 38 1.2k
Ozren Jakšić Croatia 15 407 0.6× 234 0.5× 273 0.9× 227 0.8× 233 0.9× 55 857
Rossana Maffei Italy 22 620 0.9× 335 0.8× 401 1.3× 270 0.9× 230 0.8× 46 1.2k
Athanasios Zomas Greece 18 366 0.6× 303 0.7× 207 0.7× 852 2.9× 443 1.6× 55 1.3k
Nikolaos Anagnostopoulos Greece 17 576 0.9× 456 1.0× 221 0.7× 753 2.6× 474 1.7× 41 1.3k
Janet Valdez United States 17 1.1k 1.7× 758 1.7× 608 2.0× 746 2.5× 308 1.1× 42 1.7k
SN Rabinowe United States 10 333 0.5× 348 0.8× 256 0.8× 425 1.4× 230 0.8× 16 804

Countries citing papers authored by David Hakimian

Since Specialization
Citations

This map shows the geographic impact of David Hakimian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hakimian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hakimian more than expected).

Fields of papers citing papers by David Hakimian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hakimian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hakimian. The network helps show where David Hakimian may publish in the future.

Co-authorship network of co-authors of David Hakimian

This figure shows the co-authorship network connecting the top 25 collaborators of David Hakimian. A scholar is included among the top collaborators of David Hakimian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hakimian. David Hakimian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hakimian, David, et al.. (2025). Common Variable Immunodeficiency-Like Enteropathy Associated with Rituximab B-Cell Depletion Therapy. Digestive Diseases and Sciences. 70(3). 996–999. 3 indexed citations
2.
Hakimian, David, Maria Westerhoff, Jerome Cheng, et al.. (2025). The Histologic Spectrum of Rituximab-Associated Common Variable Immunodeficiency-Like Enteropathy. Modern Pathology. 38(8). 100770–100770. 1 indexed citations
3.
4.
Butrynski, James E., John C. Paschold, Patrick J. Ward, et al.. (2024). Biomarker testing in early-stage NSCLC: Results from the MYLUNG Consortium.. Journal of Clinical Oncology. 42(16_suppl). 8047–8047. 1 indexed citations
5.
Hakimian, David, et al.. (2024). Parenteral fish oil lipid emulsion use in adults: a case series and review from an intestinal failure referral center. European Journal of Clinical Nutrition. 78(9). 796–800. 2 indexed citations
6.
Hakimian, David, Johnny Amer, Yael Milgrom, et al.. (2023). Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis. Vaccine X. 15. 100359–100359. 1 indexed citations
7.
Butrynski, James E., John C. Paschold, Patrick J. Ward, et al.. (2023). Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study.. Journal of Clinical Oncology. 41(16_suppl). 9109–9109. 3 indexed citations
8.
Amer, Johnny, David Hakimian, Yael Milgrom, et al.. (2022). Advanced Liver Fibrosis Correlates With Impaired Efficacy of Pfizer‐BioNTech COVID‐19 Vaccine in Medical Employees. Hepatology Communications. 6(6). 1278–1288. 6 indexed citations
9.
Hakimian, David, Ariel A. Benson, Tawfik Khoury, et al.. (2021). Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study. BMC Gastroenterology. 21(1). 274–274. 3 indexed citations
10.
Jotte, Robert M., Alexander I. Spira, David Waterhouse, et al.. (2021). P60.13 MYLUNG Consortium: Molecularly Informed Lung Cancer Treatment in a Community Cancer Network. Pragmatic Prospective RWR Study. Journal of Thoracic Oncology. 16(10). S1170–S1171.
11.
Benson, Ariel A., David Hakimian, Harold Jacob, & Ivo Boškoski. (2020). Closure of a chronic complex tracheoesophageal fistula by using endoscopic suturing. VideoGIE. 6(3). 119–121. 3 indexed citations
12.
Khoury, Tawfik, Muhammad Massarwa, Saleh Daher, et al.. (2018). Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients. Journal of Gastrointestinal Cancer. 50(4). 759–762. 1 indexed citations
13.
Hakimian, David, Amal Khoury, Rami Mosheiff, Meir Liebergall, & Yoram A. Weil. (2017). Radiographic markers for measuring tibial rotation based on CT-reconstructed radiographs: an accuracy and feasibility study. Skeletal Radiology. 47(4). 483–490. 8 indexed citations
14.
15.
Rosen, Adam, Kenneth Haines, Martin S. Tallman, David Hakimian, & Rosalind Ramsey‐Goldman. (1995). Rapidly progressive cutaneous vasculitis in a patient with chronic myelomonocytic leukemia. American Journal of Hematology. 50(4). 310–312. 8 indexed citations
16.
Tallman, Martin S., et al.. (1995). Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia.. Journal of Clinical Oncology. 13(4). 983–988. 53 indexed citations
17.
Hakimian, David, et al.. (1994). Prospective evaluation of internal adenopathy in a cohort of 43 patients with hairy cell leukemia.. Journal of Clinical Oncology. 12(2). 268–272. 19 indexed citations
18.
Hoffman, Mark A., Martin S. Tallman, David Hakimian, et al.. (1994). 2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 12(4). 788–792. 66 indexed citations
19.
Tallman, Martin S., et al.. (1993). Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia.. Journal of Clinical Oncology. 11(4). 690–697. 172 indexed citations
20.
Tallman, Martin S., David Hakimian, Hau C. Kwaan, & Frederick R. Rickles. (1993). New Insights into the Pathogenesis of Coagulation Dysfunction in Acute Promyelocytic Leukemia. Leukemia & lymphoma. 11(1-2). 27–36. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pasquale Iacopino Breakdown of academic impact, for papers by Jamile M. Shammo Breakdown of academic impact, for papers by Karim Maloum Breakdown of academic impact, for papers by Francesc Cobo Breakdown of academic impact, for papers by Ozren Jakšić Breakdown of academic impact, for papers by Rossana Maffei Breakdown of academic impact, for papers by Athanasios Zomas Breakdown of academic impact, for papers by Nikolaos Anagnostopoulos Breakdown of academic impact, for papers by Janet Valdez Breakdown of academic impact, for papers by SN Rabinowe
Rankless by CCL
2026